BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1096 related articles for article (PubMed ID: 29445001)

  • 1. Interventional Treatment of Severe Tricuspid Regurgitation: Early Clinical Experience in a Multicenter, Observational, First-in-Man Study.
    Lauten A; Figulla HR; Unbehaun A; Fam N; Schofer J; Doenst T; Hausleiter J; Franz M; Jung C; Dreger H; Leistner D; Alushi B; Stundl A; Landmesser U; Falk V; Stangl K; Laule M
    Circ Cardiovasc Interv; 2018 Feb; 11(2):e006061. PubMed ID: 29445001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The International Multicenter TriValve Registry: Which Patients Are Undergoing Transcatheter Tricuspid Repair?
    Taramasso M; Hahn RT; Alessandrini H; Latib A; Attinger-Toller A; Braun D; Brochet E; Connelly KA; Denti P; Deuschl F; Englmaier A; Fam N; Frerker C; Hausleiter J; Juliard JM; Kaple R; Kreidel F; Kuck KH; Kuwata S; Ancona M; Malasa M; Nazif T; Nickenig G; Nietlispach F; Pozzoli A; Schäfer U; Schofer J; Schueler R; Tang G; Vahanian A; Webb JG; Yzeiraj E; Maisano F; Leon MB
    JACC Cardiovasc Interv; 2017 Oct; 10(19):1982-1990. PubMed ID: 28982563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compassionate Use of the PASCAL Transcatheter Valve Repair System for Severe Tricuspid Regurgitation: A Multicenter, Observational, First-in-Human Experience.
    Fam NP; Braun D; von Bardeleben RS; Nabauer M; Ruf T; Connelly KA; Ho E; Thiele H; Lurz P; Weber M; Nickenig G; Narang A; Davidson CJ; Hausleiter J
    JACC Cardiovasc Interv; 2019 Dec; 12(24):2488-2495. PubMed ID: 31857018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study design and rationale of the heterotopic implantation of the Edwards-Sapien XT transcatheter valve in the inferior VEna cava for the treatment of severe tricuspid regurgitation (HOVER) trial.
    O'Neill BP; Wheatley G; Bashir R; Edmundowicz D; O'Murchu B; O'Neill WW; Patil P; Chen A; Forfia P; Cohen HA
    Catheter Cardiovasc Interv; 2016 Aug; 88(2):287-93. PubMed ID: 27122473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Outcomes of the FORMA Transcatheter Tricuspid Valve Repair System for the Treatment of Severe Tricuspid Regurgitation: Insights From the First-in-Human Experience.
    Asmarats L; Perlman G; Praz F; Hensey M; Chrissoheris MP; Philippon F; Ofek H; Ye J; Puri R; Pibarot P; Attinger A; Moss R; Bédard E; Moschovitis A; Reineke D; Lauck S; Blanke P; Leipsic J; Spargias K; Windecker S; Webb JG; Rodés-Cabau J
    JACC Cardiovasc Interv; 2019 Aug; 12(15):1438-1447. PubMed ID: 31395213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcatheter treatment of tricuspid regurgitation by caval valve implantation--experimental evaluation of decellularized tissue valves in central venous position.
    Lauten A; Laube A; Schubert H; Bischoff S; Nietzsche S; Horstkötter K; Poudel-Bochmann B; Franz M; Lichtenberg A; Figulla HR; Akhyari P
    Catheter Cardiovasc Interv; 2015 Jan; 85(1):150-60. PubMed ID: 24403276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcatheter Tricuspid Valve Repair With a New Transcatheter Coaptation System for the Treatment of Severe Tricuspid Regurgitation: 1-Year Clinical and Echocardiographic Results.
    Perlman G; Praz F; Puri R; Ofek H; Ye J; Philippon F; Carrel T; Pibarot P; Attinger A; Htun NM; Dvir D; Moss R; Campelo-Parada F; Bédard E; Reineke D; Moschovitis A; Lauck S; Blanke P; Leipsic J; Windecker S; Rodés-Cabau J; Webb J
    JACC Cardiovasc Interv; 2017 Oct; 10(19):1994-2003. PubMed ID: 28780036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Single-Site Experience With Transcatheter Tricuspid Valve Replacement.
    Hahn RT; George I; Kodali SK; Nazif T; Khalique OK; Akkoc D; Kantor A; Vahl TP; Patel A; Elias E; Ng V; Spina R; Bartus K; Velagapudi P; Wu I; Leon M; Bapat V
    JACC Cardiovasc Imaging; 2019 Mar; 12(3):416-429. PubMed ID: 30553658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1-Year Outcomes After Edge-to-Edge Valve Repair for Symptomatic Tricuspid Regurgitation: Results From the TriValve Registry.
    Mehr M; Taramasso M; Besler C; Ruf T; Connelly KA; Weber M; Yzeiraj E; Schiavi D; Mangieri A; Vaskelyte L; Alessandrini H; Deuschl F; Brugger N; Ahmad H; Biasco L; Orban M; Deseive S; Braun D; Rommel KP; Pozzoli A; Frerker C; Näbauer M; Massberg S; Pedrazzini G; Tang GHL; Windecker S; Schäfer U; Kuck KH; Sievert H; Denti P; Latib A; Schofer J; Nickenig G; Fam N; von Bardeleben RS; Lurz P; Maisano F; Hausleiter J
    JACC Cardiovasc Interv; 2019 Aug; 12(15):1451-1461. PubMed ID: 31395215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes After Current Transcatheter Tricuspid Valve Intervention: Mid-Term Results From the International TriValve Registry.
    Taramasso M; Alessandrini H; Latib A; Asami M; Attinger-Toller A; Biasco L; Braun D; Brochet E; Connelly KA; Denti P; Deuschl F; Englmeier A; Fam N; Frerker C; Hausleiter J; Himbert D; Ho EC; Juliard JM; Kaple R; Kreidel F; Kuck KH; Ancona M; Lauten A; Lurz P; Mehr M; Nazif T; Nickening G; Pedrazzini G; Pozzoli A; Praz F; Puri R; Rodés-Cabau J; Schäfer U; Schofer J; Sievert H; Sievert K; Tang GHL; Tanner FC; Vahanian A; Webb JG; Windecker S; Yzeiray E; Zuber M; Maisano F; Leon MB; Hahn RT
    JACC Cardiovasc Interv; 2019 Jan; 12(2):155-165. PubMed ID: 30594510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcatheter Valve-in-Ring Implantation for the Treatment of Residual or Recurrent Tricuspid Valve Dysfunction After Prior Surgical Repair.
    Aboulhosn J; Cabalka AK; Levi DS; Himbert D; Testa L; Latib A; Makkar RR; Boudjemline Y; Kim DW; Kefer J; Bleiziffer S; Kerst G; Dvir D; McElhinney DB
    JACC Cardiovasc Interv; 2017 Jan; 10(1):53-63. PubMed ID: 28057286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined Tricuspid and Mitral Versus Isolated Mitral Valve Repair for Severe MR and TR: An Analysis From the TriValve and TRAMI Registries.
    Mehr M; Karam N; Taramasso M; Ouarrak T; Schneider S; Lurz P; von Bardeleben RS; Fam N; Pozzoli A; Lubos E; Boekstegers P; Schillinger W; Plicht B; Eggebrecht H; Baldus S; Senges J; Maisano F; Hausleiter J;
    JACC Cardiovasc Interv; 2020 Mar; 13(5):543-550. PubMed ID: 31954679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Severe TRIcuspid Regurgitation in Patients with Advanced Heart Failure with CAval Vein Implantation of the Edwards Sapien XT VALve (TRICAVAL): a randomised controlled trial.
    Dreger H; Mattig I; Hewing B; Knebel F; Lauten A; Lembcke A; Thoenes M; Roehle R; Stangl V; Landmesser U; Grubitzsch H; Stangl K; Laule M
    EuroIntervention; 2020 Apr; 15(17):1506-1513. PubMed ID: 31929100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bicaval TricValve Implantation in Patients With Severe Symptomatic Tricuspid Regurgitation: 1-Year Follow-Up Outcomes.
    Blasco-Turrión S; Briedis K; Estévez-Loureiro R; Sánchez-Recalde A; Cruz-González I; Pascual I; Mascherbauer J; Abdul-Jawad Altisent O; Nombela-Franco L; Pan M; Trillo R; Moreno R; Delle Karth G; Sánchez-Luna JP; Gonzalez-Gutiérrez JC; Revilla-Orodoea A; Zamorano JL; Gómez-Salvador I; Puri R; San Román JA; Amat-Santos IJ
    JACC Cardiovasc Interv; 2024 Jan; 17(1):60-72. PubMed ID: 38069986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Massive or Torrential Tricuspid Regurgitation in Patients Undergoing Transcatheter Tricuspid Valve Intervention.
    Miura M; Alessandrini H; Alkhodair A; Attinger-Toller A; Biasco L; Lurz P; Braun D; Brochet E; Connelly KA; de Bruijn S; Denti P; Deuschl F; Estevez-Loureiro R; Fam N; Frerker C; Gavazzoni M; Hausleiter J; Himbert D; Ho E; Juliard JM; Kaple R; Besler C; Kodali S; Kreidel F; Kuck KH; Latib A; Lauten A; Monivas V; Mehr M; Muntané-Carol G; Nazif T; Nickenig G; Pedrazzini G; Philippon F; Pozzoli A; Praz F; Puri R; Rodés-Cabau J; Schäfer U; Schofer J; Sievert H; Tang GHL; Thiele H; Rommel KP; Vahanian A; Von Bardeleben RS; Webb JG; Weber M; Windecker S; Winkel M; Zuber M; Leon MB; Maisano F; Hahn RT; Taramasso M;
    JACC Cardiovasc Interv; 2020 Sep; 13(17):1999-2009. PubMed ID: 32912460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined Mitral and Tricuspid Versus Isolated Mitral Valve Transcatheter Edge-to-Edge Repair in Patients With Symptomatic Valve Regurgitation at High Surgical Risk.
    Besler C; Blazek S; Rommel KP; Noack T; von Roeder M; Luecke C; Seeburger J; Ender J; Borger MA; Linke A; Gutberlet M; Thiele H; Lurz P
    JACC Cardiovasc Interv; 2018 Jun; 11(12):1142-1151. PubMed ID: 29929635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermediate term hemodynamic effects of single inferior vena cava valve implant for the treatment of severe tricuspid regurgitation.
    Rakita V; Lakhter V; Patil P; O'Neill BP
    Catheter Cardiovasc Interv; 2017 Sep; 90(3):521-525. PubMed ID: 28168785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 6-Month Outcomes of the TricValve System in Patients With Tricuspid Regurgitation: The TRICUS EURO Study.
    Estévez-Loureiro R; Sánchez-Recalde A; Amat-Santos IJ; Cruz-González I; Baz JA; Pascual I; Mascherbauer J; Abdul-Jawad Altisent O; Nombela-Franco L; Pan M; Trillo R; Moreno R; Delle Karth G; Salido-Tahoces L; Santos-Martinez S; Núñez JC; Moris C; Goliasch G; Jimenez-Quevedo P; Ojeda S; Cid-Álvarez B; Santiago-Vacas E; Jimenez-Valero S; Serrador A; Martín-Moreiras J; Strouhal A; Hengstenberg C; Zamorano JL; Puri R; Íñiguez-Romo A
    JACC Cardiovasc Interv; 2022 Jul; 15(13):1366-1377. PubMed ID: 35583363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of Procedural and Clinical Outcomes in Patients With Symptomatic Tricuspid Regurgitation Undergoing Transcatheter Edge-to-Edge Repair.
    Besler C; Orban M; Rommel KP; Braun D; Patel M; Hagl C; Borger M; Nabauer M; Massberg S; Thiele H; Hausleiter J; Lurz P
    JACC Cardiovasc Interv; 2018 Jun; 11(12):1119-1128. PubMed ID: 29929631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcatheter Tricuspid Valve-in-Valve Replacement With Subsequent Bioprosthetic Valve Fracture to Optimize Hemodynamic Function.
    Hensey M; Alenezi AR; Murdoch DJ; Sathananthan J; Weir-McCall JR; Wood D; Blanke P; Webb J
    JACC Cardiovasc Interv; 2018 Nov; 11(21):2226-2227. PubMed ID: 30343018
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 55.